Tag archive for ‘OrbiMed’
Gil Tanenbaum On Thursday, December 18th, 2014

Israel’s Nutrina Raises $12 Million for Pre-Term Infant Insulin Treatment

Israeli company Nutrinia, which develops oral insulin therapies to treat rare gastrointestinal disorders, has raised $12 million. The company said that funds from the round will be used to advance two multinational More...

Jewish Business News On Thursday, July 24th, 2014

Infections treatment co Atox Bio raises $23 million

– Atox Bio will conduct a Phase II study for a soft tissue infections treatment. Atox Bio, which develops therapeutics for severe infections, has raised up to $23 million in a Series E investment More...

Gil Tanenbaum On Tuesday, May 27th, 2014

OrbiMed’s Israel Fund Invests $14 Million In Keystone Heart Ltd.

– Keystone Heart has received funding from OrbiMed’s Israel Life Science Fund. – – In a Series B financial round led by OrbiMed, Israel’s developer of the TriGaurd, Keystone Heart More...

Johnson & Johnson Innovation Expands Global Incubator Presence to Israel

Johnson & Johnson Innovation announced that it is expanding its global incubator presence through a novel collaboration with the Office of the Chief Scientist in Israel and other industry partners to establish More...

Contributor On Tuesday, June 11th, 2013

Johnson&Johnson, OrbiMed, AstraZeneca and Takeda to bid for Israeli biotech incubator

– AstraZeneca and Japan’s Takeda will bid against Johnson & Johnson and OrbiMed for the Chief Scientist’s tender. – – /By Gali Weinreb / UK pharmaceutical company AstraZeneca More...

Wordpress site Developed by Fixing WordPress Problems